Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.
A new paper by UC San Diego researchers hypothesizes a possible link between cancer-causing viruses.
U.S. News & World Report today released its 2020 guidebook that ranks the nation’s top graduate programs and professional schools, giving high marks to UC San Diego’s innovative programs.
UC San Diego researchers have discovered an unexpected mechanism that allows bacteria to defend themselves against antibiotics, a finding that could lead to retooled drugs to treat infectious diseases.
An engineering-surgery team at UC San Diego is working to extend the reach of surgeons by allowing them to operate remotely on patients located across a city, country, or even the globe. They are developing predictive augmented reality systems that could help make telesurgery a reality.
UC San Diego's Clinical Bioengineering course offers undergraduate engineering students hands-on learning experience to solve clinical problems. The course reflects the Institute of Engineering in Medicine's mission to connect engineers with physicians to produce medical innovations.
UC San Diego researchers studying p53, the heralded cancer-fighting “guardian of the genome,” found that the human protein also plays a role in promoting tumors, in addition to suppressing them.
Using active genetics technology, biologists have developed the world’s first CRISPR/Cas9-based approach to control genetic inheritance in a mammal. The achievement in mice lays the groundwork for further advances based on this technology, including biomedical research on human disease.
The Trestles supercomputer, which was acquired more than three years ago by the Arkansas High Performance Computing Center (AHPCC) at the University of Arkansas after entering service at the San Diego Supercomputer Center in 2011, is still going strong.
A new study by researchers from several universities including UC San Diego, published earlier this month in ACS Central Science, suggests a novel approach to fighting the sometimes deadly influenza virus.